Retractable Technologies Stock
Retractable Technologies, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Thomas J. Shaw
- Employees
- 198
- Market cap
- $17 M
- IPO
- 04/05/2001
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international…
Retractable Technologies stock: price history
1D
-2.0%
1W
-13.1%
1M
-15.3%
6M
-14.0%
YTD
-25.4%
1Y
-41.2%
2Y
-27.0%
5Y
-93.7%
10Y
-77.7%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~12% weaker price swings than usual
Ask the agents about Retractable Technologies
Retractable Technologies stock metrics
P/E
-4.78
P/B
0.24
EV/EBITDA
3.38
RETURN ON EQUITY
3.9%
NET MARGIN
39.3%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
40.8%
FLOAT SHARES
12,205,080
AVG. DAILY VOLUME (30D)
32,442
Institutional holders
Comparable stocks
Frequently asked questions about Retractable Technologies stock
What does Retractable Technologies do?
Retractable Technologies, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Thomas J. Shaw, the company employs around 198 people.
The IPO was on 04/05/2001; the stock trades on AMEX under the ticker RVP.
When does Retractable Technologies report next?
Around past earnings, price swings were roughly -12% stronger than usual.
Does Retractable Technologies pay a dividend?
No, Retractable Technologies currently does not pay a dividend.
Which stocks are comparable to Retractable Technologies?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Avantor.
How can I get Retractable Technologies stock analyzed?
Clicking "Analyze stock" lets five strategies assess Retractable Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.